Drug intelligence / Profile preview

bacolin

Development stage
Unknown
Lead developer
Institute of Materia Medica, Chinese Academy of Medical Sciences
Modality
Small Molecules
Administration
Oral
01

Overview

Bacolin is a small molecule drug candidate developed by the Institute of Materia Medica, Chinese Academy of Medical Sciences (IMM CAMS) for the treatment of Parkinson's disease. Classified as a Class 1.1 innovative drug in China, Bacolin is a flavonoid derivative designed to target multiple pathological pathways of the disease. Its primary mechanism of action involves the inhibition of alpha-synuclein aggregation, which is a hallmark of Parkinson's disease pathology. Additionally, it demonstrates neuroprotective effects through antioxidant and anti-inflammatory activities. Bacolin is currently in Phase 1 clinical development, with studies focusing on its safety, tolerability, and pharmacokinetic profile in healthy volunteers and elderly populations in China.

Other names
巴考林
02

Targets

aggregated α-syn (Alpha-synuclein (α-syn))

Beyond the preview

Go deeper on bacolin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bacolin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call